Form 8-K - Current report:
SEC Accession No. 0001628280-25-031219
Filing Date
2025-06-13
Accepted
2025-06-13 13:20:33
Documents
12
Period of Report
2025-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K abcl-20250612.htm   iXBRL 8-K 32250
  Complete submission text file 0001628280-25-031219.txt   142553

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abcl-20250612.xsd EX-101.SCH 1788
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abcl-20250612_lab.xml EX-101.LAB 20678
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abcl-20250612_pre.xml EX-101.PRE 11962
15 EXTRACTED XBRL INSTANCE DOCUMENT abcl-20250612_htm.xml XML 2593
Mailing Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6
Business Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39781 | Film No.: 251045582
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)